Corbus Pharmaceuticals Holdings Inc
Change company Symbol lookup
Select an option...
CRBP Corbus Pharmaceuticals Holdings Inc
BAC Bank of America Corp
KO Coca-Cola Co
HXL Hexcel Corp
RDHL Redhill Biopharma Ltd
WASH Washington Trust Bancorp Inc
ADC Agree Realty Corp
FB Facebook Inc
HSTM HealthStream Inc
AMZN Amazon.com Inc
Go

Health Care : Biotechnology | Small Cap GrowthCompany profile

Corbus Pharmaceuticals Holdings, Inc. is a Phase-III, clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company operates through developing and commercializing therapeutics to treat rare life-threatening inflammatory fibrotic diseases segment. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and halt fibrotic processes. Lenabasum stimulates the production of Specialized Pro-Resolving Lipid Mediators (SPMs) that act to resolve inflammation, and halt fibrosis by activating endogenous pathways. The Company is developing lenabasum to treat four diseases: systemic sclerosis, cystic fibrosis, diffuse cutaneous, skin-predominant dermatomyositis and systemic lupus erythematosus (SLE).

Postmarket

Last Trade
Delayed
$5.98
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$5.98
Day's Change
-0.15 (-2.45%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
6.19
Day's Low
5.95
Volume
(Light)
Volume:
391,065

10-day average volume:
510,614
391,065
  • Prev Close
    6.13
  • Today's Open
    6.17
  • Day's Range
    5.95-6.19
  • Avg Vol (10-day)
    510.6K
  • Last (time)
    4:00p ET 07/23/19
  • Last (size)
    1
  • 52-Wk Range
    4.50 - 9.11
    LowHigh
  • (08/08/18 - 02/15/19)
    32.89%
  • 76.8%
  • Market Cap
    385.4M
  • Shares Outstanding
    64.5M
  • -1.19
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.8
  • 47.14
  • (% of float 06/28/19)
    26.73

Latest News

June 17, 2019
8:09 am ET
Globe Newswire
June 10, 2019
6:39 pm ET
BusinessWire
June 03, 2019
12:20 pm ET
MarketWatch
May 29, 2019
8:05 am ET
Globe Newswire
May 15, 2019
8:06 am ET
Globe Newswire
May 13, 2019
4:38 pm ET
Globe Newswire
3:01 pm ET
Globe Newswire
May 10, 2019
11:41 am ET
Globe Newswire
May 09, 2019
4:53 pm ET
Globe Newswire
3:36 pm ET
Globe Newswire
May 08, 2019
10:01 pm ET
Globe Newswire
6:55 pm ET
Globe Newswire
May 05, 2019
8:39 am ET
Globe Newswire
May 02, 2019
8:03 pm ET
Globe Newswire
6:49 pm ET
Globe Newswire
5:21 pm ET
Globe Newswire
May 01, 2019
8:05 am ET
Globe Newswire
April 26, 2019
3:25 pm ET
Globe Newswire
1:17 pm ET
MarketWatch
9:15 am ET
Globe Newswire
April 25, 2019
2:27 pm ET
Globe Newswire
9:05 am ET
BusinessWire
March 28, 2019
9:12 am ET
MarketWatch
March 19, 2019
7:24 am ET
MarketWatch
February 22, 2019
9:29 am ET
MarketWatch
February 13, 2019
4:19 pm ET
MarketWatch
February 11, 2019
11:17 am ET
MarketWatch
August 07, 2017
7:05 am ET
Market Wire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2019 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2019. All rights reserved.